Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Rediject D-Luciferin Ultra is pre-formulated with a fluorescent marker to validate your substrate injection. With PerkinElmer’s Rediject D-Luciferin Ultra you can ensure reproducible results by minimizing variability due to formulation and substrate injection, minimizing freeze/thaw and controlling batch to batch variation.
Rediject D-Luciferin Ultra is pre-formulated with a rapidly clearing fluorescent dye to validate the integrity of your substrate injection, so with a quick fluorescent image on your IVIS system you know immediately if an injection failed and you can normalize your bioluminescence results. With Rediject D-Luciferin Ultra bioluminescent substrate, you can have extra confidence in your data quality.
For laboratory use only. This product is intended for animal research only and not for use in humans.
|Quantity in a Package Amount||1.0 Units|
|Shipping Condition||Blue Ice|
|Unit Size||10 vials|
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.